SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-018776
Filing Date
2022-12-19
Accepted
2022-12-19 08:00:48
Documents
15
Period of Report
2022-12-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20221219x8k.htm   iXBRL 8-K 40891
2 EX-99.1 tmb-20221219xex99d1.htm EX-99.1 32789
3 GRAPHIC tmb-20221219xex99d1001.jpg GRAPHIC 14345
  Complete submission text file 0001558370-22-018776.txt   232866

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20221219.xsd EX-101.SCH 3810
5 EX-101.DEF tmb-20221219_def.xml EX-101.DEF 3498
6 EX-101.LAB tmb-20221219_lab.xml EX-101.LAB 17262
7 EX-101.PRE tmb-20221219_pre.xml EX-101.PRE 10065
9 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221219x8k_htm.xml XML 4889
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 221469642
SIC: 2834 Pharmaceutical Preparations